Amber Hussain Siddique
Amber Hussain Siddique, Director of Finance at Dr Reddy's Laboratories Inc., is emerging as a prominent force behind strategic finance transformation in the global pharmaceutical industry. A Chartered Accountant by qualification, Siddique brings over eight years of progressive experience in financial planning, controlling, and business leadership across international markets.

Based in New Jersey, Siddique leads the finance controlling function across multiple geographies, managing a cross-border team spanning the United States and India.

His responsibilities include budgeting, forecasting, business performance review of both base and new business, cost governance, inventory management, and treasury function. Supporting business units with annual budgets running into hundreds of millions of dollars, he plays a mission-critical role in executive decision-making and long-term corporate strategy.

The work of Siddique resonates well with the mission of Dr Reddy to "accelerate access to affordable and innovative medicines because Good Health Can't Wait." Through a series of high-impact savings initiatives, he has helped generate multi-million-dollar efficiencies, directly enabling the company to expand access to affordable medicines for patients across the United States and India.

One of his most significant achievements was to spearhead the financial due diligence and inventory review of a $90 million acquisition. Siddique personally reviewed $25 million dollars of inventory in over ten different manufacturing and distribution locations in the U.S., Canada, Australia and India. His detailed analysis uncovered critical discrepancies, resulting in direct savings of $1.6 million. The multidimensional project demanded close collaboration with various contract manufacturing sites and global supply-chain partners.

In addition to M&A projects, Siddique leads enterprise-wide cost reduction initiatives that have delivered multi-million-dollar annual savings in the form of product cost-improvement, vendor renegotiations, operating expenses efficiency, and strategic working capital management. Among his most impactful initiatives is a freight-cost optimization program on India-U.S. shipments, delivering $1 million dollars annual savings and directly supporting company's mission to offer one of the essential medicines at a lower price while expanding market share.

To strengthen financial governance, Siddique developed 27 executive dashboards providing real-time visibility into budget versus actual spending. These tools are now used monthly by senior leadership to enhance accountability, improve decision-making, and prevent cost overruns.
In inventory management, he introduced advanced monthly analytics frameworks in collaboration with supply chain and commercial teams. The initiative reduced excess and obsolete inventory, enabled recovery of blocked stock, improved forecasting accuracy, and significantly lowered write-offs.

Siddique further demonstrated his risk-management expertise by identifying a critical system defect affecting First-Expiry-First-Out (FEFO) compliance in UPS system. His findings led to the creation of an internal FEFO tracking mechanism, preventing violations and avoiding an estimated $2 million in potential inventory losses.

In recognition of his impact, Siddique has received multiple internal honors. Most recently, he was awarded "Best Finance Controller" at Dr Reddy's global annual leadership event for delivering exceptional results in cost optimization and profitability improvement, contributing to more than $27 million in cost reductions through strategic projects.

Beyond his corporate role, Siddique has built a strong international profile. He was invited as a global speaker at World Finance Forum, where he presented on financial planning and analysis (FP&A) transformation, focusing on strategic partnering, value creation, automation and data driven decision making.

He is also invited as a Guest Lecturer at Rutgers University, New Jersey, where he will train students on the major pharmaceutical industry themes, such as the patent cliff, FDA accelerated approval pathways, supply chain disruptions and drug pricing, and the rise of biosimilars. This activity is an indication of his passion for sharing knowledge and training the future generation of the financial and healthcare professional.

Siddique is also a peer reviewer for Sciedu Press Journal, where he reviews academic research on finance and corporate governance. His review supports publication decisions and strengthens the bridge between industry practice and scholarly research.

His professional credibility extends to global award platforms, where he was selected to act as a judge for Globee Awards (Leadership category) and the Stevie Awards (Great Employers category). Trust in his professional judgment is demonstrated by the fact that he is the one to review and mark leadership and organizational excellence submissions independently.

Siddique's leadership philosophy emphasizes collaboration, accountability, and talent development. He actively mentors finance professionals and is known for building high-performing teams that operate with transparency and ownership. His approach makes finance a strategic growth engine and not a traditional reporting tool.

Representing a new generation of finance leaders, Siddique combines technical excellence with strong commercial acumen. His work demonstrates how financial leadership can drive operational agility, sustainable growth, and shareholder value creation in highly regulated industries.
As his international profile continues to expand, Siddique remains deeply engaged in thought leadership through speaking engagements, academic involvement, and industry forums. His career reflects a sustained commitment to professional excellence, cross-functional collaboration, and ethical leadership.

The story of Amber Hussain Siddique is an example for upcoming finance professional across the globe- illustrating how knowledge, integrity and strategic vision can create an impactful leadership career.